Stocksigma LogoStocksigma Logo

Godavari Drugs Reports Zero Fund Deviation for Q2 FY27

Godavari Drugs Limited submitted its Statement of Deviation or Variation for the quarter ended 30th Sep'26, confirming nil deviation in utilizing proceeds

Godavari Drugs Reports Zero Fund Deviation for Q2 FY27

Godavari Drugs Ltd · Others (Uncategorized) · 11 Nov 2026, 11:14 pm

Godavari Drugs Reports Zero Fund Deviation for Q2 FY27 Godavari Drugs Limited submitted its Statement of Deviation or Variation for the quarter ended 30th Sep'26, confirming nil deviation in utilizing proceeds raised via preferential issue. Out of total proceeds of ₹4,411.73 lakhs raised on 18th Mar'26, the company allocated ₹1,100.00 lakhs to capital expenditure (₹796.31 lakhs utilized), ₹1,711.73 lakhs to working capital (₹0.00 utilized), and ₹1,600.00 lakhs toward repayment of unsecured promoter/director loans (₹400.00 lakhs utilized). Total funds utilized stand at ₹1,196.31 lakhs. The Audit Committee and Board approved the filing on 11th Nov'26.

Original exchange filing (PDF)

More announcements from Godavari Drugs Ltd

All Godavari Drugs Ltd announcements